
Andy Beck, CEO PathAI
Beyond the Scope
00:00
Transforming Pathology with AI: Vision and Strategy
This chapter explores the foundational motivations for establishing an AI company in the pathology sector, focusing on the transformative potential of technology in drug development and diagnostics. The conversation underscores the importance of diverse applications and the future advancements expected in pathology over the next ten years.
Transcript
Play full episode